Thierry Soussi

18PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 28, 2025
Misclassification of TP53 germline variants: implications for survival analysis in AML transplant studies.

Léa Rodriguez, François Delhommeau, Thierry Soussi

|Sep 15, 2025
A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Thierry Soussi, Snehangshu Kundu, Pauline Gerbaud

|Jun 17, 2025
The TP53 tumor suppressor gene: From molecular biology to clinical investigations.

Panagiotis Baliakas, Thierry Soussi

|Apr 14, 2025
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots.

Grégory Lazarian, Bernard Leroy, Floriane Theves

|Mar 06, 2025
TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma.

Grégory Lazarian, Lotfi Chemali, Merieme Bensalah

|Jan 08, 2025
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations.

Julianne S Funk, Maria Klimovich, Daniel Drangenstein

Pageof 3